Answers are grounded in this paper and cite their sources.
Background: Various adjuvants have been tried to improve quality and increase duration of local anesthetics during various nerve blocks.We aimed to evaluate the efficacy of midazolam as an adjunct for RS block to reduce the need for morphine, discomfort, nausea, and vomiting after surgery.Patients and methods: 66 Cases undergoing umbilical hernia repair randomized into two groups Midazolam group 33 cases, received bilateral administration of bupivacaine 0.25% 20 ml, combined with 50 mcg/kg midazolam, and control group 33 cases, received the same anesthesia without addition of midazolam.Results: Heart rate was comparable between groups and patients in the midazolam group exhibited lower MBP with no significant difference.The control group experienced higher morphine rescue analgesia than the midazolam.The 24-h morphine consumption was more declined among patients in the midazolam group.Static and dynamic VAS recordings were more declined in midazolam group against the control group.Cases in the midazolam group exhibited higher satisfaction score with lower Postoperative nausea and vomiting (PONV) (P <0.01).Conclusion: Midazolam administration as an adjunct to bupivacaine during rectus sheath block increased analgesic qualities, as demonstrated by lower VAS grades, lower postoperative morphine doses, and a longer time to first request of analgesia.Midazolam also showed antiemetic actions, and no major side effects were observed.
No takes yet. Share an insight, caveat, or question.
Younes et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: